Igor Splawski, PhD


Chief Scientific Officer

Igor Splawski, PhD, has been appointed as Chief Scientific Officer (CSO) in July 2020. Mr. Splawski joined the Novartis Institutes for BioMedical Research (NIBR) in Cambridge, MA, in 2005. Since 2018, he was an Executive Director and Site Head of the NIBR Biologics Center. In his function, Igor led more than 100 scientists to identify and evaluate protein, mRNA, and adeno-associated virus (AAV) targets, including a collaboration with a clinical group to identify and validate drug targets from human genetics. He was an Assistant Professor at Harvard Medical School from 2005 to 2008.

Igor has a PhD in human genetics from the University of Utah and an MSc in biotechnology from Sofia University. He is an inventor on 26 patents, and author of 22 research publications.

Back to Executive Board